Iopidine

Apraclonidine, the active ingredient in Iopidine, is a alpha-2 adrenergic agonist presented as a 0.5% ophthalmic solution for ocular (topical) use. It treats elevated intra‑ocular pressure in conditions such as glaucoma and ocular hypertension, and is also used to manage post‑operative ocular inflammation.

GNH USA supplies Iopidine as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance.

Iopidine (apraclonidine) is used in ocular conditions that involve elevated intra‑ocular pressure or postoperative inflammation. - Glaucoma: reduces intra‑ocular pressure to help prevent optic nerve damage. - Ocular hypertension: lowers intra‑ocular pressure in patients with elevated pressure but no optic nerve damage. - Post‑operative ocular inflammation: decreases intra‑ocular pressure and inflammation after eye surgery.

Iopidine may cause ocular and systemic adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Burning or stinging sensation: transient discomfort upon instillation. - Redness of the eye: mild conjunctival hyperemia. - Blurred vision: temporary visual disturbance. - Dry eye: reduced tear production. - Foreign body sensation: feeling of something in the eye.

Serious or Rare Side Effects: - Allergic reaction: swelling, rash, or severe eye irritation. - Corneal edema: swelling of the cornea affecting vision. - Severe ocular inflammation: persistent redness, pain, or discharge. - Systemic hypotension: low blood pressure if absorbed in significant amounts.

Before using Iopidine, consider the following precautions to ensure safe and effective therapy. - Pregnancy: safety not established; avoid unless benefit outweighs risk. - Breastfeeding: unknown excretion; caution advised. - Pre‑existing ocular conditions: use with care in patients with severe dry eye or corneal disease. - Concomitant ocular medications: monitor for additive pressure‑lowering effects. - Systemic cardiovascular disease: watch for hypotension in susceptible individuals. - Store at room temperature: keep below 25 °C, protect from light and moisture, retain in original container.

Iopidine can interact with other agents, influencing ocular pressure or systemic effects.

Major Interactions (Avoid): - Beta‑blocker eye drops: additive intra‑ocular pressure reduction may cause excessive lowering. - Systemic alpha‑2 agonists (e.g., clonidine): risk of enhanced hypotensive effect.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory eye drops: may affect corneal healing. - Anticholinergic eye drops: potential for reduced efficacy. - Systemic antihypertensives: monitor blood pressure for additive hypotension.